Testing for HIV drug resistance
The development of a highly sensitive assay for the detection of drug-resistant HIV strains could aid our understanding of how the virus mutates, helping new drug discovery programs.
Archives for January 19, 2007
Chemical weapons vaccine enters clinical trials
A vaccine that protects against the effects of nerve agents often used in chemical weapons is ready to be tested on human volunteers, according to developer Baxter Healthcare.
'Trojan Horse' vaccines for malaria, TB and AIDS
More effective and easier to administer 'Trojan horse' vaccines could provide protection for the millions of people at risk from malaria, TB and AIDS, thanks to a breakthrough from a global research team.
Competitors fill void left by CodeLink exit
Agilent, Illumina, NimbleGen and Oxford Gene Technology have stepped into the breach caused by GE Healthcare's decision to scrap its CodeLink arrays.
Bayer Schering Pharma brings in cancer specialists VTT
Bayer Schering Pharma has decided to collaborate with Finnish biotechnology specialists to study the mode of action of their new cancer drug.
'Global centre of microarray excellence'
Oxford Gene Technology and Agilent are to collaborate to develop a global centre of microarray excellence focused on new and emerging applications.
No entry for malaria parasite
Researchers have discovered a new antimalarial therapy that acts by targeting the method of entry of the parasite into red blood cells.